Targeting Runt-DNA binding may be selective for BC cells as RUNX2 is not expressed in normal mammary epithelial cells [17, 41], but it would be of a concern in normal cells that express RUNX1 and/or RUNX3. This evidence concerns the gene RUNX3 and breast cancer.